How the Weight-Loss Drugs Differ Patients receive Ozempic and Wegovy as a subcutaneous injection
Thats because the active ingredient, semaglutide, will no longer be binding to the GLP-1 receptors in your body to control your appetite
Scientists from Harvard & Johns Hopkins
However, microdosing is considered an off-label practice with limited clinical research, and professional organizations including the American Diabetes Association do not formally endorse it
As with any supplement, results vary depending on individual factors, but many users report increased energy levels, fat loss, and improved overall well-being
However, broader real-world use over time will always reveal more about rare events and tolerability across diverse populations, so continued post-market evidence is important